(2S,4R)-1-[(2R)-2-[3-[(1S)-2-[(3R)-3-[(6aS)-5,6,6a,7,9,10-Hexahydro-2-(2-hydroxyphenyl)-8H-pyrazino[1′,2′:4,5]pyrazino[2,3-c]pyridazin-8-yl]-1-pyrrolidinyl]-1-methylethoxy]-5-isoxazolyl]-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]

Request For Quotation
(2S,4R)-1-[(2R)-2-[3-[(1S)-2-[(3R)-3-[(6aS)-5,6,6a,7,9,10-Hexahydro-2-(2-hydroxyphenyl)-8H-pyrazino[1′,2′:4,5]pyrazino[2,3-c]pyridazin-8-yl]-1-pyrrolidinyl]-1-methylethoxy]-5-isoxazolyl]-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-2-pyrrolidinecarboxamide Basic information
Product Name:(2S,4R)-1-[(2R)-2-[3-[(1S)-2-[(3R)-3-[(6aS)-5,6,6a,7,9,10-Hexahydro-2-(2-hydroxyphenyl)-8H-pyrazino[1′,2′:4,5]pyrazino[2,3-c]pyridazin-8-yl]-1-pyrrolidinyl]-1-methylethoxy]-5-isoxazolyl]-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-2-pyrrolidinecarboxamide
Synonyms:(2S,4R)-1-[(2R)-2-[3-[(1S)-2-[(3R)-3-[(6aS)-5,6,6a,7,9,10-Hexahydro-2-(2-hydroxyphenyl)-8H-pyrazino[1′,2′:4,5]pyrazino[2,3-c]pyridazin-8-yl]-1-pyrrolidinyl]-1-methylethoxy]-5-isoxazolyl]-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-2-pyrrolidinecarboxamide;SMARCA2 degrader-17
CAS:2755761-78-3
MF:C47H58N10O6S
MW:891.09
EINECS:
Product Categories:
Mol File:2755761-78-3.mol
(2S,4R)-1-[(2R)-2-[3-[(1S)-2-[(3R)-3-[(6aS)-5,6,6a,7,9,10-Hexahydro-2-(2-hydroxyphenyl)-8H-pyrazino[1′,2′:4,5]pyrazino[2,3-c]pyridazin-8-yl]-1-pyrrolidinyl]-1-methylethoxy]-5-isoxazolyl]-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-2-pyrrolidinecarboxamide Structure
(2S,4R)-1-[(2R)-2-[3-[(1S)-2-[(3R)-3-[(6aS)-5,6,6a,7,9,10-Hexahydro-2-(2-hydroxyphenyl)-8H-pyrazino[1′,2′:4,5]pyrazino[2,3-c]pyridazin-8-yl]-1-pyrrolidinyl]-1-methylethoxy]-5-isoxazolyl]-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-2-pyrrolidinecarboxamide Chemical Properties
density 1.40±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)
pka6.32±0.30(Predicted)
Safety Information
MSDS Information
(2S,4R)-1-[(2R)-2-[3-[(1S)-2-[(3R)-3-[(6aS)-5,6,6a,7,9,10-Hexahydro-2-(2-hydroxyphenyl)-8H-pyrazino[1′,2′:4,5]pyrazino[2,3-c]pyridazin-8-yl]-1-pyrrolidinyl]-1-methylethoxy]-5-isoxazolyl]-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-2-pyrrolidinecarboxamide Usage And Synthesis
UsesPRT3789 is a SMARCA2 PROTAC degrader (DC50 in HeLa cell: 0.72 nM for SMARCA2, 14 nM for SMARCA4). PRT3789 shows synergistic anti-proliferation effects with Adagrasib (HY-130149) in cancer cells. PRT3789 inhibits SMARCA4-mutated lung cancer proliferation. PRT3789 inhibits tumor growth in SMARCA4-deleted NSCLC models. Pink: SMARCA4 ligand (HY-44824) ; Blue: VHL ligand (HY-159465) ; Black: linker; VHL ligand+linker (HY-172738)[1].
References[1] Koichi Ito, et al. Improved treatment of cancers using combinations of smarca2 degraders and kras targeting therapies. Patent. WO2024076985A2
(2S,4R)-1-[(2R)-2-[3-[(1S)-2-[(3R)-3-[(6aS)-5,6,6a,7,9,10-Hexahydro-2-(2-hydroxyphenyl)-8H-pyrazino[1′,2′:4,5]pyrazino[2,3-c]pyridazin-8-yl]-1-pyrrolidinyl]-1-methylethoxy]-5-isoxazolyl]-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-2-pyrrolidinecarboxamide Preparation Products And Raw materials
Tag:(2S,4R)-1-[(2R)-2-[3-[(1S)-2-[(3R)-3-[(6aS)-5,6,6a,7,9,10-Hexahydro-2-(2-hydroxyphenyl)-8H-pyrazino[1′,2′:4,5]pyrazino[2,3-c]pyridazin-8-yl]-1-pyrrolidinyl]-1-methylethoxy]-5-isoxazolyl]-3-methyl-1-oxobutyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-5-thiazolyl)phenyl]ethyl]-2-pyrrolidinecarboxamide(2755761-78-3) Related Product Information
dTAGV-1 ARV-766 DT2216 Acetamide, N-[7-[(3R)-3-[[5-chloro-4-[[2-[(1-methylethyl)sulfonyl]phenyl]amino]-2-pyrimidinyl]amino]-1-piperidinyl]heptyl]-2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- AU-15330 ARV-771